Top Stocks to Hold for the Long Term
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 46 minutes ago
0mins
Source: Fool
- Nintendo's Lasting Appeal: Nintendo (NTDOY) sold 20 million units of the Switch 2 last fiscal year, with similar projections for the next year, maintaining a strong market share; despite a 54% drop from its highs, its long-term investment potential remains robust.
- Oscar Health's Market Disruption: Oscar Health (OSCR) increased its customer base from 1 million to 3.2 million over the past year, with projected revenue of $19 billion in 2023, showcasing strong expansion and improving profitability in the health insurance sector.
- Adyen's Payment Processing Edge: Adyen (ADYEY) reported a 21% year-over-year growth in processed volume and a 20% revenue increase in Q1 2026, even as its stock is down 66% from all-time highs, indicating significant growth potential in the global payments market.
- Strategic Importance of Long-Term Investment: The continuous innovation and market share growth of these companies suggest they will provide substantial returns for investors over the next 20 years, especially in the context of economic fluctuations, highlighting the enduring value of holding quality businesses.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to fall
8 Analyst Rating
1 Buy
4 Hold
3 Sell
Hold
Current: 22.140
Low
11.00
Averages
15.75
High
25.00
Current: 22.140
Low
11.00
Averages
15.75
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Top Stocks to Hold for the Long Term
- Nintendo's Lasting Appeal: Nintendo (NTDOY) sold 20 million units of the Switch 2 last fiscal year, with similar projections for the next year, maintaining a strong market share; despite a 54% drop from its highs, its long-term investment potential remains robust.
- Oscar Health's Market Disruption: Oscar Health (OSCR) increased its customer base from 1 million to 3.2 million over the past year, with projected revenue of $19 billion in 2023, showcasing strong expansion and improving profitability in the health insurance sector.
- Adyen's Payment Processing Edge: Adyen (ADYEY) reported a 21% year-over-year growth in processed volume and a 20% revenue increase in Q1 2026, even as its stock is down 66% from all-time highs, indicating significant growth potential in the global payments market.
- Strategic Importance of Long-Term Investment: The continuous innovation and market share growth of these companies suggest they will provide substantial returns for investors over the next 20 years, especially in the context of economic fluctuations, highlighting the enduring value of holding quality businesses.
See More
Oscar Health CEO Discusses Growth Strategy Against Giants
- Market Positioning: Oscar Health, as a small insurer in the ACA market, aims to challenge the dominance of traditional insurance giants through innovative networks and technology, demonstrating a strong competitive intent in the market.
- Technology-Driven: CEO Mark Bertolini emphasizes that Oscar enhances consumer experience through technology, enabling users to enjoy more efficient services in healthcare, thereby increasing customer loyalty and satisfaction.
- Differentiated Network: Oscar's network design differs from traditional insurers, aiming to provide more flexible healthcare options, which not only attracts new customers but also creates a unique value proposition in a highly competitive market.
- Growth Plans: Oscar is actively implementing growth plans, leveraging its unique market positioning and technological advantages to expand market share and enhance brand influence in the coming years.
See More
Oscar Health's Growth Strategy and Market Positioning
- Unique Market Positioning: Oscar Health, a small insurer in the ACA market, focuses on individual plans and leverages its network to keep costs low, thereby attracting customers to remain within its ecosystem, showcasing a distinct approach compared to traditional insurers.
- Technology-Driven Experience: CEO Mark Bertolini emphasizes that Oscar enhances consumer experience through technology, optimizing service processes and increasing customer satisfaction and loyalty, which further solidifies its competitive position in the market.
- Competing with Giants: As an underdog in the market, Oscar Health aims to challenge the dominance of large insurers through a flexible network and innovative service models, demonstrating significant growth potential in the healthcare insurance industry.
- Investor Attention: Despite Oscar Health's strong market performance, the analyst team notes that it is currently not on the list of top investment stocks, advising investors to carefully consider its market performance before making investment decisions.
See More
Glynn Capital Management Exits Klaviyo Position Before Earnings Drop
- Exit Transaction: Glynn Capital Management sold all 456,805 shares of Klaviyo in Q1 2026, with an estimated transaction value of $9.80 million, reflecting a cautious stance on market prospects.
- Value Decline: The sale and stock price movement resulted in a $14.83 million decline in Glynn's Klaviyo position value, indicating the company's unfavorable performance in the market.
- Performance Discrepancy: Despite Klaviyo's revenue increasing by 28% year-over-year to $358 million and non-GAAP operating income nearly doubling to $58.6 million, the stock plummeted 32% post-earnings, highlighting valuation pressures.
- Future Outlook: Klaviyo still holds nearly $985 million in cash, and despite stock volatility, long-term investors may find the current low price point offers a more attractive investment opportunity.
See More
BARCLAYS INCREASES OSCAR HEALTH INC. TARGET PRICE TO $21, UP FROM $18
- Barclays Raises Price Target: Barclays has increased its price target for Oscar Health from $18 to $21.
- Market Implications: This adjustment reflects Barclays' positive outlook on Oscar Health's performance in the market.
See More
US Stocks Surge as Tech Stocks Lead Gains
- Tech Stocks Rally: The Nasdaq 100 surged 2.08% to reach an all-time high on Wednesday, driven by stellar earnings from chipmakers and AI infrastructure firms, particularly Advanced Micro Devices, which rose over 17% as it raised its full-year sales forecast, reflecting strong investor optimism about ongoing AI investments.
- Crude Oil Plunge: WTI crude oil prices fell more than 7% to a two-week low as market expectations for a US-Iran peace agreement increased, easing inflation fears and contributing to stock market gains, with the 10-year Treasury yield dropping to a one-week low of 4.33%.
- Employment Data Impact: The April ADP employment report indicated that US companies added 109,000 jobs, below the expected 120,000, yet the market remains optimistic about the Fed's monetary policy, believing it will help maintain a low interest rate environment.
- International Market Surge: Overseas stock markets closed sharply higher, with the Euro Stoxx 50 rising 2.68% and China's Shanghai Composite gaining 1.17%, indicating a positive global market response to the US economic recovery, further boosting investor confidence.
See More
Top Stocks to Hold for the Long Term
- Nintendo's Lasting Appeal: Nintendo (NTDOY) sold 20 million units of the Switch 2 last fiscal year, with similar projections for the next year, maintaining a strong market share; despite a 54% drop from its highs, its long-term investment potential remains robust.
- Oscar Health's Market Disruption: Oscar Health (OSCR) increased its customer base from 1 million to 3.2 million over the past year, with projected revenue of $19 billion in 2023, showcasing strong expansion and improving profitability in the health insurance sector.
- Adyen's Payment Processing Edge: Adyen (ADYEY) reported a 21% year-over-year growth in processed volume and a 20% revenue increase in Q1 2026, even as its stock is down 66% from all-time highs, indicating significant growth potential in the global payments market.
- Strategic Importance of Long-Term Investment: The continuous innovation and market share growth of these companies suggest they will provide substantial returns for investors over the next 20 years, especially in the context of economic fluctuations, highlighting the enduring value of holding quality businesses.
See More
Oscar Health CEO Discusses Growth Strategy Against Giants
- Market Positioning: Oscar Health, as a small insurer in the ACA market, aims to challenge the dominance of traditional insurance giants through innovative networks and technology, demonstrating a strong competitive intent in the market.
- Technology-Driven: CEO Mark Bertolini emphasizes that Oscar enhances consumer experience through technology, enabling users to enjoy more efficient services in healthcare, thereby increasing customer loyalty and satisfaction.
- Differentiated Network: Oscar's network design differs from traditional insurers, aiming to provide more flexible healthcare options, which not only attracts new customers but also creates a unique value proposition in a highly competitive market.
- Growth Plans: Oscar is actively implementing growth plans, leveraging its unique market positioning and technological advantages to expand market share and enhance brand influence in the coming years.
See More
Oscar Health's Growth Strategy and Market Positioning
- Unique Market Positioning: Oscar Health, a small insurer in the ACA market, focuses on individual plans and leverages its network to keep costs low, thereby attracting customers to remain within its ecosystem, showcasing a distinct approach compared to traditional insurers.
- Technology-Driven Experience: CEO Mark Bertolini emphasizes that Oscar enhances consumer experience through technology, optimizing service processes and increasing customer satisfaction and loyalty, which further solidifies its competitive position in the market.
- Competing with Giants: As an underdog in the market, Oscar Health aims to challenge the dominance of large insurers through a flexible network and innovative service models, demonstrating significant growth potential in the healthcare insurance industry.
- Investor Attention: Despite Oscar Health's strong market performance, the analyst team notes that it is currently not on the list of top investment stocks, advising investors to carefully consider its market performance before making investment decisions.
See More
Glynn Capital Management Exits Klaviyo Position Before Earnings Drop
- Exit Transaction: Glynn Capital Management sold all 456,805 shares of Klaviyo in Q1 2026, with an estimated transaction value of $9.80 million, reflecting a cautious stance on market prospects.
- Value Decline: The sale and stock price movement resulted in a $14.83 million decline in Glynn's Klaviyo position value, indicating the company's unfavorable performance in the market.
- Performance Discrepancy: Despite Klaviyo's revenue increasing by 28% year-over-year to $358 million and non-GAAP operating income nearly doubling to $58.6 million, the stock plummeted 32% post-earnings, highlighting valuation pressures.
- Future Outlook: Klaviyo still holds nearly $985 million in cash, and despite stock volatility, long-term investors may find the current low price point offers a more attractive investment opportunity.
See More
BARCLAYS INCREASES OSCAR HEALTH INC. TARGET PRICE TO $21, UP FROM $18
- Barclays Raises Price Target: Barclays has increased its price target for Oscar Health from $18 to $21.
- Market Implications: This adjustment reflects Barclays' positive outlook on Oscar Health's performance in the market.
See More
US Stocks Surge as Tech Stocks Lead Gains
- Tech Stocks Rally: The Nasdaq 100 surged 2.08% to reach an all-time high on Wednesday, driven by stellar earnings from chipmakers and AI infrastructure firms, particularly Advanced Micro Devices, which rose over 17% as it raised its full-year sales forecast, reflecting strong investor optimism about ongoing AI investments.
- Crude Oil Plunge: WTI crude oil prices fell more than 7% to a two-week low as market expectations for a US-Iran peace agreement increased, easing inflation fears and contributing to stock market gains, with the 10-year Treasury yield dropping to a one-week low of 4.33%.
- Employment Data Impact: The April ADP employment report indicated that US companies added 109,000 jobs, below the expected 120,000, yet the market remains optimistic about the Fed's monetary policy, believing it will help maintain a low interest rate environment.
- International Market Surge: Overseas stock markets closed sharply higher, with the Euro Stoxx 50 rising 2.68% and China's Shanghai Composite gaining 1.17%, indicating a positive global market response to the US economic recovery, further boosting investor confidence.
See More
